4Li S H,Chan S C,Toshitani A,et al.Synergistic effects of interleukin 4 and interferon-gamma on monocyte phosphodiesterase activity[J].J Invest Dermatol,1992,99:65-70.
5Ahmad F,Gao G,Wang LM,et al.IL-3 and IL-4 activate cyclic adenosine monophodiesterase 3 and 4 by different mechanisms in FDCP2 myeloid cells[J].J Immunol,1999,162:4864-75.
6Souness J E,Aldous D,Sargent C.Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors[J].Immunopharmacology,2000,47(2-3):127-62.
7Grewe S E,Chan S C,Hanifin J M.Elevated leukocyte cyclic AMP phosphodiesterase in atopic disease:A possible mechanism for cAMP hyporesponsiveness[J].J Allergy Clin Immunol,1982,70:452-7.
8Holden C A,Chan S C,Hanifin J M.Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis[J].J Invest Dermatol,1986,87:372-6.
9Chan S C,Hanifin J M.Differential inhibitor effect on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes[J].J Lab Clin Med,1993,121:44-51.
10Sawai T,Ikai K,Uehara M.Cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from patients with atopic dermatitis:Correlation with respiratory atopy[J].Br J Dermatol,1998,138(5):846-8.
